Medical News

RSS

Scivanta Medical announces initial clinical trial results for SCMS

Scivanta Medical Corporation, today announced that the results of its initial clinical trial for the Scivanta Cardiac Monitoring System (SCMS) clearly indicate that the SCMS can accurately measure cardiac performance as expected by the company. This clinical trial was performed at Kaleida Health/Millard Fillmore Hospital in Buffalo, New York.

10 Mar 2010

Landmark legislation to protect frail nursing home residents in Illinois

In one newspaper story after another, a grave issue came under the spotlight: thousands of frail seniors live in inappropriate conditions at dozens of Illinois nursing homes – sharing living quarters with dangerous individuals, suffering abuse or neglect, and even receiving the wrong medications for their ailments.

10 Mar 2010

MIT researchers to use Elekta Neuromag system to study neural basis of brain disorders

Researchers at MIT are eagerly anticipating the summer delivery of Elekta Neuromag®, a system that uses magnetoencephalography or MEG to explore brain function. MEG can detect the very weak magnetic fields arising from electrical activity in the brain, and allows researchers to monitor the timing of brain activity with millisecond precision.

From Elekta 10 Mar 2010

Study shows strawberries can provide immense health benefits

When it comes to eating healthy, most people know it's a good long-term choice, but what they may not know is that eating certain foods daily can provide immediate health benefits.

10 Mar 2010

Kendle implements new biostatistics infrastructure to enhance delivery of quality clinical trial data

Kendle, a leading, global full-service clinical research organization, today announced the implementation of a new biostatistics infrastructure that will significantly enhance the analysis and delivery of quality clinical trial data for customers.

10 Mar 2010

Many doctors, hospitals unhappy with health IT rules, despite windfall

Though the federal government plans to give doctors up to $44,000 each, as well as millions of dollars to hospitals, to help buy health information technology, many providers are unhappy with the stimulus-funded program, the Huffington Post Investigative Fund reports. "Some rural health organizations fear the program could exacerbate a 'digital divide' by concentrating the funding in elite hospitals that already computerize their records."

10 Mar 2010

Helix BioMedix announces additional funding of $2.9M through convertible promissory notes

Helix BioMedix, Inc., a developer of bioactive peptides, announced additional funding in the amount of $2.9 million through convertible promissory notes. The company also announced the addition of Lawrence Blake Jones to its board of directors.

10 Mar 2010

Genetic variant increases risk of lung cancer for light and heavy smokers, say researchers

Individuals with a certain type of genetic susceptibility to lung cancer face a greatly increased risk for the deadly disease with even a small exposure to cigarette smoke, a study team that includes researchers from the University of Cincinnati has concluded.

10 Mar 2010

Long term care facilities receive increased scrutiny

The New York Times: "The Senate Finance Committee has opened an investigation into patient deaths and allegations of substandard treatment at long-term care hospitals, small specialty medical centers that treat chronically ill patients. The investigation focuses on the Select Medical Corporation, a for-profit corporation that runs 89 long-term care hospitals, more than any other company."

9 Mar 2010

Researchers identify a new mechanism for tumor control

The interaction of a ligand (Neurotrophine-3) and its dependence receptor (TrkC) constitutes a novel mechanism for tumor control in pediatric cancers such as neuroblastoma, and may also be important to the inhibition of other cancers such as breast cancer.

9 Mar 2010

Bruker to acquire certain product lines of Varian

Varian, Inc. announced today that Bruker Corporation and Agilent Technologies, Inc. have entered into a definitive asset purchase agreement pursuant to which Bruker will acquire certain product lines of Varian. As previously announced, Agilent committed to divest those product lines in connection with obtaining regulatory approval for Agilent's pending acquisition of Varian.

9 Mar 2010

Dems discuss plans to advance health reform; Opposition steps up its game

"Sen. Tom Harkin (D-Iowa), the chairman of the Senate Health, Education, Labor and Pensions (HELP) Committee, predicted that the Congress would wrap up its healthcare bills for President Barack Obama's signature before lawmakers leave for a holiday recess." He said he believed "that we will have the bill on the president's desk by the time we leave on March 27th."

9 Mar 2010

A contemplative approach to understand the secrets of lasting happiness

Philosophers, historians, economists, social scientists and creative arts practitioners will gather next week at the University of Hertfordshire to discuss what happiness means and how a greater depth of the state can be achieved.

9 Mar 2010

FDA's Advisory Committee votes 9-3 to recommend approval of Esbriet for treatment of patients with IPF

InterMune, Inc. announced today that the U.S. Food and Drug Administration's Pulmonary-Allergy Drugs Advisory Committee voted 9-3 to recommend approval of Esbriet® (pirfenidone) for the treatment of patients with idiopathic pulmonary fibrosis (IPF) to reduce decline in lung function.

9 Mar 2010

Cornyn and Boehner sharpen criticism of Obama health proposal

"National Republican Senatorial Committee Chairman John Cornyn said Monday that if some type of health care legislation is able to limp its way out of Congress, GOP candidates across the country are poised to make it the premiere issue of the fall campaign," Politico reports. "While Cornyn said his personal preference would be to stop a bill entirely, his campaign committee is already preparing its attack line for a scenario that assumes Democrats squeeze a bill through the controversial reconciliation process in the next month."

9 Mar 2010

NIH awards Phase I SBIR grant to DNA Medicine Institute for emergency blood sensor

The DNA Medicine Institute, a commercial organization focused on advancing human health through innovation, today announced that it has been awarded a Phase I Small Business Innovation Research grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health.

9 Mar 2010

Aton Pharma introduces authorized generic version of Timoptic-XE

Aton Pharma, Inc., a diversified specialty pharmaceutical company, today announced that it has launched an authorized generic version of its Timoptic-XE® (timolol maleate ophthalmic gel forming solution). Timoptic-XE is a non-selective beta-adrenergic receptor blocking agent indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open-angle glaucoma. Aton also announced that it will continue to make available branded Timoptic-XE.

9 Mar 2010

Abbott announces definitive agreement to acquire Facet Biotech

Abbott and Facet Biotech Corporation announced today a definitive agreement for Abbott to acquire Facet, enhancing Abbott's early- and mid-stage pharmaceutical pipeline.

9 Mar 2010

Senate test vote today on bill to extend COBRA subsidy, doc fix and state Medicaid funding

The Senate is poised to consider a measure today that would include extending subsidies for COBRA benefits and unemployment insurance, prevent the Medicare payment cut for doctors and provide additional funding to state Medicaid programs.

9 Mar 2010

ACIST Medical Systems to provide CVi contrast injection system to HealthTrust Purchasing Group

ACIST Medical Systems, Inc., a world-leading provider of contrast-delivery systems for cardiology and radiology imaging, announced today that HealthTrust Purchasing Group, LP (HealthTrust), Brentwood, Tenn., one of the leading health care group purchasing organizations, has awarded the company a three-year contract, effective December 1, 2009, for ACIST cardiovascular injection technology, the ACIST | CVi® Contrast Delivery System.

9 Mar 2010

Medical News

Scivanta Medical announces initial clinical trial results for SCMS

Landmark legislation to protect frail nursing home residents in Illinois

MIT researchers to use Elekta Neuromag system to study neural basis of brain disorders

Study shows strawberries can provide immense health benefits

Kendle implements new biostatistics infrastructure to enhance delivery of quality clinical trial data

Many doctors, hospitals unhappy with health IT rules, despite windfall

Helix BioMedix announces additional funding of $2.9M through convertible promissory notes

Genetic variant increases risk of lung cancer for light and heavy smokers, say researchers

Long term care facilities receive increased scrutiny

Researchers identify a new mechanism for tumor control

Bruker to acquire certain product lines of Varian

Dems discuss plans to advance health reform; Opposition steps up its game

A contemplative approach to understand the secrets of lasting happiness

FDA's Advisory Committee votes 9-3 to recommend approval of Esbriet for treatment of patients with IPF

Cornyn and Boehner sharpen criticism of Obama health proposal

NIH awards Phase I SBIR grant to DNA Medicine Institute for emergency blood sensor

Aton Pharma introduces authorized generic version of Timoptic-XE

Abbott announces definitive agreement to acquire Facet Biotech

Senate test vote today on bill to extend COBRA subsidy, doc fix and state Medicaid funding

ACIST Medical Systems to provide CVi contrast injection system to HealthTrust Purchasing Group

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News